Nanomaterials in Biomass Conversion

She earned a Ph.D. in chemistry from Government College University Faisalabad Pakistan in 2016 and carried out research work at the University of Pennsylvania, Philadelphia, Pennsylvania, United States. She is interested in synthesizing molecules that possess interesting functions, including biological activity (natural products, drugs, drug-like compounds etc.) or materials with useful properties. She develops tools to perform efficient synthetic transformations in creating novel molecular architectures of medicinal or industrial relevance. In a nutshell, my interests are broadly in synthetic organic chemistry, with a particular focus on the synthesis of bioactive natural products and novel molecular architectures (nanomaterials). She worked on organic synthesis focused on catalysis, visible light photoredox couplings, transition metal-catalyzed -couplings, and click chemistry. Synthesis of nanomaterials and their applications to control environmental pollution is also her area of interest. Muhammad Bilal is working as an Associate Professor at the Faculty of Civil and Environmental Engineering, Gdansk University of Technology, Poland. Previously, he served as an assistant/associate Professor at Poznan University of Technology, Poland, and the School of Life Science and Food Engineering, Huaiyin Institute of Technology, Huaian, China. He earned his Ph.D. from Shanghai Jiao Tong University, specializing in bioengineering and applied biotechnology. His main research activities are oriented to Environmental biotechnology, nanotechnology, enzyme engineering, immobilization, chemical modifications, and industrial applications of microbial enzymes, liquid, and solid waste management. He has authored over 700 peer-reviewed articles, 150 book chapters, 25 edited books. Dr. Bilal is the associate editor of Frontiers in Chemical Engineering and Frontiers in Environmental Science (Frontiers), and an editorial board member for several journals. He was listed as a highly cited researcher (Clarivate) in 2021 and holds several "highly cited papers" in WOS.